Advances in the Management of Prostate Cancer: New Insights into Biological and Clinical Factors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 1 January 2025 | Viewed by 126
Special Issue Editors
Interests: big data; biostatistics; computer science; statistical analysis and applications
Special Issue Information
Dear Colleagues,
Prostate cancer remains a major global health concern, with ongoing developments enhancing our understanding of its biological mechanisms and clinical management. This Special Issue aims to explore the latest advancements in the management of prostate cancer, highlighting innovative diagnostic tools, risk stratification models and tailored therapeutic strategies, such as androgen receptor signaling inhibitors, targeted therapies and innovations in surgical and radiation therapy.
We invite submissions of original research articles and comprehensive reviews that provide new insights into these areas. This Special Issue intends to foster interdisciplinary collaboration and serve as a vital resource for researchers, clinicians and healthcare professionals dedicated to enhancing patient outcomes through integrated scientific discovery and clinical application.
We look forward to your contributions and advancing our collective understanding and management of prostate cancer.
Dr. Yetkin Tuac
Dr. Mutlay Sayan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- risk stratification
- genomic alterations
- radiation therapy
- prostatectomy
- androgen deprivation therapy
